Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra, Gianluca Svegliati‐Baroni
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 280-295
Closed Access | Times Cited: 687

Showing 1-25 of 687 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3279
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2018) Vol. 65, pp. 37-55
Open Access | Times Cited: 891
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 731
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Mario Masarone, Valerio Rosato, Marcello Dallio, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 559
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan, Rambabu Surabattula, Xiaoyu Wang
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 238-250
Closed Access | Times Cited: 419
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 3, pp. 135-149
Open Access | Times Cited: 414
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 396
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 391
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH
I. Pierantonelli, Gianluca Svegliati‐Baroni
Transplantation (2018) Vol. 103, Iss. 1, pp. e1-e13
Open Access | Times Cited: 366
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 330
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 287
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future
Scott L. Friedman, Massimo Pinzani
Hepatology (2021) Vol. 75, Iss. 2, pp. 473-488
Open Access | Times Cited: 284
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell, Jörn M. Schattenberg, Isabelle Leclercq, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 2241-2257
Open Access | Times Cited: 276
Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Adel Hammoutène, Pierre‐Emmanuel Rautou
Journal of Hepatology (2019) Vol. 70, Iss. 6, pp. 1278-1291
Open Access | Times Cited: 271
Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial
Samer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1809-1824
Open Access | Times Cited: 259
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque, Gyöngyi Szabó, Manal F. Abdelmalek, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 24-39
Closed Access | Times Cited: 240
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere, Frank Tacke
JHEP Reports (2019) Vol. 1, Iss. 1, pp. 30-43
Open Access | Times Cited: 231
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Jinchunzi Yang, Marta Fernández‐Galilea, Leyre Martínez‐Fernández, et al.
Nutrients (2019) Vol. 11, Iss. 4, pp. 872-872
Open Access | Times Cited: 229
Metabolic Messengers: ceramides
Scott A. Summers, Bhagirath Chaurasia, William L. Holland
Nature Metabolism (2019) Vol. 1, Iss. 11, pp. 1051-1058
Open Access | Times Cited: 225
A new perspective on NAFLD: Focusing on lipid droplets
Eleonora Scorletti, Rotonya M. Carr
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 934-945
Open Access | Times Cited: 219
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis
Yong Rao, Zhiqi Kuang, Chan Li, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 205
Challenges and opportunities in NASH drug development
Stephen A. Harrison, Alina M. Allen, Julie Dubourg, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 562-573
Closed Access | Times Cited: 194
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Gianluca Svegliati‐Baroni, I. Pierantonelli, Pierangelo Torquato, et al.
Free Radical Biology and Medicine (2019) Vol. 144, pp. 293-309
Closed Access | Times Cited: 193
Polystyrene microplastics induce hepatotoxicity and disrupt lipid metabolism in the liver organoids
Wei Cheng, Xiaolan Li, Yue Zhou, et al.
The Science of The Total Environment (2021) Vol. 806, pp. 150328-150328
Closed Access | Times Cited: 192
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 177
Page 1 - Next Page

Scroll to top